Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Endocrinology|June 12, 2025
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomasGerald Raverot, Pia Burman, Ana Paula Abreu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and NivolumabAndrew L Lin, Philip Jonsson, Viviane Tabar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa Rudneva, Adam Newton, et al.
Neuro-Oncology|November 29, 2013
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomasAndrew L Lin, Jingxia Liu, John Evans, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
The Oncologist|April 17, 2026
Characterization and Clinical Management of Adverse Events Following Treatment with Repotrectinib: A TRIDENT-1 AnalysisAlexander Drilon, Byoung Chul Cho, D Ross Camidge, et al.
The Oncologist|May 8, 2026
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysisAlexander Drilon, Byoung Chul Cho, D Ross Camidge, et al.
JCO Precision Oncology|February 25, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem GliomasMarina Kushnirsky, Andrew L Lin, Tejus Bale, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
Acta Neuropathologica|May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
Pageof 4